Stocks With The Most
Fund Put Options
| Name | Net Calls | Puts | Calls |
Return since 31 Mar ‘22 |
|
|---|---|---|---|---|---|
| $26.8M | $78.2M | $51.5M | 84.7% |
|
|
| $26.6M | $28.5M | $1.9M | 59% |
|
|
| $26.5M | $28.5M | $1.98M | 20.4% |
|
|
379
Lincoln National
LNC
$7.56B
| $26.4M | $102M | $75.2M | 39% |
|
| $26.4M | $104M | $78.1M | 84.3% |
|
|
| $26.3M | $98.3M | $71.9M | 92.3% |
|
|
| $26.1M | $261M | $235M | 51.4% |
|
|
| $25.4M | $94.3M | $68.9M | 6.27% |
|
|
| $24.6M | $46M | $21.4M | 65.3% |
|
|
| $24.5M | $45.5M | $21M | 31.9% |
|
|
386
Pacira BioSciences
PCRX
$1.01B
| $24.1M | $26.9M | $2.75M | 70.6% |
|
| $24M | $35.2M | $11.2M | 43.9% |
|
|
| $24M | $33M | $9M | 75% |
|
|
| $24M | $37M | $13M | 44.4% |
|
|
| $23.9M | $25.1M | $1.27M | 22.8% |
|
|
| $23.9M | $26.9M | $3.02M | 46.4% |
|
|
| $23.8M | $2.66B | $2.64B | 29.4% |
|
|
| $23.8M | $43.2M | $19.4M | 20.8% |
|
|
| $23.7M | $101M | $76.9M | 63.1% |
|
|
| $23.5M | $218M | $195M | 97.8% |
|
|
| $23.4M | $59.5M | $36M | 81.9% |
|
|
| $23.3M | $118M | $95.1M | 107% |
|
|
| $23.3M | $91.6M | $68.3M | 4.55% |
|
|
| $23.2M | $125M | $101M | 69.8% |
|
|
| $22.9M | $33.7M | $10.7M | 11% |
|